Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astaxanthin Supplementation in Acute Ischemic Stroke
NCT03945526Phase 1Completed
- Sponsor
- Universitas Indonesia
- Start
- Mar 2010
- Primary completion
- Jun 2010
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Plasma Malondialdehyde Levels at 7 days and National Institute of Health Stroke Scale at 7 days. Started Mar 2010; status: completed.
Beyond the preview
Go deeper on NCT03945526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03945526.